Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

Share Price Information for Iconic Labs (ICON)

Share Price is delayed by 15 minutes
Get Live Data
1.70    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.20 (11.429%)
Market Cap: £272.68k
ICON Live PriceLast checked at - London Stock Exchange

Intraday Iconic Labs Share Chart

Infotagion Update

8 Apr 2020 09:37

RNS Number : 2064J
Iconic Labs PLC
08 April 2020
 

 

 

8 April 2020

 

 

Iconic Labs Plc ("Iconic Labs" or the "Company")

Media Launch of Infotagion is Viewed by 1million readers

 

Iconic Labs Plc (LSE:ICON) (the "Company"), a multi-divisional new media and technology business, announces the successful launch of Infotagion by reaching 1million readers.

 

The Company announced last week that, in partnership with Damian Collins MP, former Chair of the Parliamentary Committee on Culture, Media and Sport, it had established a service to counter the dissemination of incorrect information, in particular through social media, that relates to the Covid-19 pandemic and its related economic and social effects.

 

In just a matter of days the media launch resulted in more than 70 pieces of individual news covered by the UK's major news outlets including the BBC, ITV, Daily Mail, WIRED, Yahoo, radio and local and specialist news sites.

 

The phenomenal success of the media launch meant that at least 1million readers viewed the news; it was shared across social media nearly three thousand times and also verified by Facebook and Twitter.

 

The full list of media coverage surrounding Infotagion can be found here: https://www.iconiclabs.co.uk/infotagion-the-battle-against-disinformation/

 

In addition to this the group of supporters within governments and organisations around the world continues to grow and the full list is updated on the Infotagion website.

 

The company has been approached by a number of global organisations about using the Infotagion platform and data. The company looks forward to updating the market with the progress of these plans.

 

John Quinlan, Chief Executive Officer of Iconic Labs, said: ""We are delighted with the launch of Infotagion. To receive such a response in such a short period of time just goes to show how important this service is to the public. The support has been unprecedented and the platform is growing day by day. For Twitter and Facebook to verify us so quickly also shows a level of cooperation and trust from them and we thank them for their support. We plan to keep growing this platform and increasing the awareness of what Infotagion and Iconic Labs can achieve."

 

Social media is providing to be a very powerful and important asset to our communities in the current crisis. In particular it provides one the most effective means by which people can maintain essential interaction with others, and preserve communities, during this period of social distancing and isolation.

However, there is another side in that social media is one of the primary forums in which disinformation, whether circulated innocently or deliberately, is prevalent. We are therefore very pleased to be able to play a role in helping to counter disinformation about the current Covid-19 pandemic by bringing our expertise and skills to bear on the problem."

 

Infotagion

 

The core of the service is a website (www.infotagion.co.uk ) on which users post screenshots of information which they have received from social media or elsewhere. The submitted information is checked by a team organised by Mr Collins, which includes experts from, inter alia, the WHO and Parliament.

 

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

**ENDS**

 

For further information, please visit the Company's website www.iconiclabs.co.uk or contact:

 

Damon Heath

Shard Capital Partners LLP

Tel: +44 (0) 20 7186 9950

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDSSDSAAESSEDL
Date   Source Headline
9th Jun 202611:55 amRNSHolding(s) in Company
9th Jun 202611:54 amRNSHolding(s) in Company
9th Jun 202611:53 amRNSHolding(s) in Company
9th Jun 202611:52 amRNSHolding(s) in Company
9th Jun 202611:51 amRNSHolding(s) in Company
9th Jun 202611:50 amRNSHolding(s) in Company
2nd Jun 20265:18 pmRNSConversion of Notes and Allotment of Shares
29th May 20267:00 amRNSTotal Voting Rights
29th Apr 202612:58 pmRNSConversion of Notes and Allotment of Shares
31st Mar 20267:00 amRNSInterim Results
27th Feb 202610:23 amRNSTotal Voting Rights
23rd Feb 20267:00 amRNSConversion of Notes and Allotment of Shares
31st Dec 202511:37 amRNSResult of AGM
8th Dec 20252:16 pmRNSNotice of AGM
23rd Oct 20252:30 pmRNSFull Year Results
12th Aug 20252:04 pmRNSUpdate on Compliance with UK Listing Rules
30th Jun 20253:27 pmRNSHolding(s) in Company
30th Jun 20253:25 pmRNSHolding(s) in Company
30th Jun 20257:00 amRNSTotal Voting Rights
9th Jun 20254:28 pmRNSConversion of Notes and Allotment of Shares
6th Jun 20259:48 amRNSConversion of Notes and Allotment of Shares
3rd Jun 20252:54 pmRNSConversion of Notes and Allotment of Shares
30th May 20254:00 pmRNSConversion of Notes and Allotment of Shares
28th May 20255:24 pmRNSConversion of Notes and Allotment of Shares
28th May 20254:54 pmRNSHolding(s) in Company
28th May 20254:52 pmRNSHolding(s) in Company
28th May 20254:50 pmRNSHolding(s) in Company
28th May 20254:48 pmRNSHolding(s) in Company
20th May 20257:30 amRNSRestoration Iconic Labs Plc
20th May 20257:00 amRNSRestoration of Trading and Funding Update
15th May 20254:18 pmRNSResult of AGM
24th Apr 20255:16 pmRNSNotice of AGM
31st Mar 20256:41 pmRNSInterim Results
31st Mar 20255:26 pmRNSRevised Results for the Year ended 30 June 2024
13th Feb 20255:55 pmRNSTransaction Terminated
7th Feb 20252:52 pmRNSNotification of Major Holdings
31st Oct 20243:57 pmRNSFull Year Results for the Year ended 30 June 2024
9th Sep 20247:00 amRNSWaiver of Event of Default
10th Jul 20244:22 pmRNSBoard Changes
28th Mar 20247:00 amRNSInterim Results
11th Mar 202412:00 pmRNSHeads of Terms Signed
29th Feb 20247:00 amRNSTotal Voting Rights
29th Feb 20247:00 amRNSSuspension of Trading
13th Feb 20242:08 pmRNSResult of AGM
7th Feb 20249:10 amRNSConversion of Notes and Allotment of Shares
19th Jan 20243:49 pmRNSNotice of AGM
4th Jan 20247:00 amRNSBoard Changes & Business and Strategy Update
29th Dec 20237:00 amRNSTotal Voting Rights
7th Dec 20238:53 amRNSConversion of Securities
4th Dec 20237:53 amRNSConversion of Securities

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.